DarioHealth (DRIO) Net Cash Flow (2016 - 2025)

DarioHealth filings provide 13 years of Net Cash Flow readings, the most recent being -$10.1 million for Q4 2025.

  • On a quarterly basis, Net Cash Flow fell 187.56% to -$10.1 million in Q4 2025 year-over-year; TTM through Dec 2025 was -$6.0 million, a 33.41% increase, with the full-year FY2025 number at -$6.0 million, up 33.41% from a year prior.
  • Net Cash Flow hit -$10.1 million in Q4 2025 for DarioHealth, down from $10.0 million in the prior quarter.
  • In the past five years, Net Cash Flow ranged from a high of $52.6 million in Q1 2021 to a low of -$17.3 million in Q2 2021.
  • Median Net Cash Flow over the past 5 years was -$7.4 million (2023), compared with a mean of -$343150.0.
  • The widest YoY moves for Net Cash Flow: up 1251.08% in 2021, down 552.0% in 2021.
  • DarioHealth's Net Cash Flow stood at -$15.6 million in 2021, then surged by 50.35% to -$7.7 million in 2022, then grew by 4.02% to -$7.4 million in 2023, then surged by 255.87% to $11.6 million in 2024, then plummeted by 187.56% to -$10.1 million in 2025.
  • The last three reported values for Net Cash Flow were -$10.1 million (Q4 2025), $10.0 million (Q3 2025), and -$6.0 million (Q2 2025) per Business Quant data.